Ended up 30% today to .026 on high volume with no news, outstanding breakout and/or reversal, director has been buying. With a chart like this something has to be happening.
Company blurb...
Through the acquisition of Sun Biomedical Laboratories Inc (SBL), HGR has acquired a portfolio of unique invitro diagnostic intellectual property with a specific focus and expertise in the use of saliva as the diagnostic medium. The immediate opportunity to be realised through SBL is the global commercialisation of their benchmark oral-fluid illicit drug screening device OraLine which has established an industry benchmark with the most sensitive detection levels particularly for marijuana which is the most commonly consumed illicit substance both in Australia, the United States and throughout Europe.
Company blurb...
Through the acquisition of Sun Biomedical Laboratories Inc (SBL), HGR has acquired a portfolio of unique invitro diagnostic intellectual property with a specific focus and expertise in the use of saliva as the diagnostic medium. The immediate opportunity to be realised through SBL is the global commercialisation of their benchmark oral-fluid illicit drug screening device OraLine which has established an industry benchmark with the most sensitive detection levels particularly for marijuana which is the most commonly consumed illicit substance both in Australia, the United States and throughout Europe.